ZEPTIGRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Dec 2021)
What this means for you
This application is over — abandoned 20 Dec 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87890425
- Mark type
- Stylized text
- Filed
- 24 Apr 2018
- Published for opposition
- 18 Sept 2018
- Abandoned
- 20 Dec 2021
- Attorney of record
- Maren C. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, and neurological disorders and conditions
Owner
- LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC., BOTHELL, WA, US
- Alder BioPharmaceuticals, Inc., Bothell, WA, US
- Alder BioPharmaceuticals, Inc., Bothell, WA, US
Prosecution history
- 20 Dec 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Dec 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2021 — SOU EXTENSION 5 GRANTED
- 08 Apr 2021 — SOU EXTENSION 5 FILED
- 22 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Apr 2021 — SOU TEAS EXTENSION RECEIVED
- 13 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2020 — SOU EXTENSION 4 GRANTED
- 09 Oct 2020 — SOU EXTENSION 4 FILED
- 09 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2020 — SOU EXTENSION 3 GRANTED
- 27 Apr 2020 — SOU EXTENSION 3 FILED
- 27 Apr 2020 — SOU TEAS EXTENSION RECEIVED